Overexpression of glutathione S-transferase α in clear cell renal cell carcinoma

American Journal of Clinical Pathology

Volumn 123, Issue 3, 2005, Pages 421-429

  Chuang, Shang Tian ^a   Chu, Peiguo ^b   Sugimura, Jun ^e   Tretiakova, Maria S ^c   Papavero, Veronica ^a   Wang, Kim ^a   Tan, Minhan ^e   Lin, Fan ^a,d   Teh, Bin T ^e   Yang, Ximing J ^a,f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d GEISINGER HEALTH SYSTEM   (United States)

^e VAN ANDEL RESEARCH INSTITUTE   (United States)

^f NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Complementary DNA micro array; Glutathione S transferase ; GST ; Immunohistochemistry; Renal cell carcinoma

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA MICROARRAY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 20044364767     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AQXR6B2QPUGD638C     Document Type: Article

References (25)

1. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-1631.
2. Takahashi M, Rhodes DR, Purge KA, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA. 2001;98:9754-9759.
3. Takahashi M, Yang XJ, Lavery TT, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res. 2002;62:6598-6605.
4. Higgins JPT, Shinghal R, Gill H, et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol. 2003;162:925-932.
5. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms. Am J Pathol. 2001;158:1639-1651.
6. Takahashi M, Yang XJ, Sugimura J, et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogens. 2003;22:6810-6818.
7. Tretiakova MS, Sahoo S, Takahashi M, et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004;28:69-76.
8. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130-7139.
9. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445-600.
10. Dekant W. Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation. Toxicol Lett. 1993;67:151-160.
11. O'Brien ML, Tew KD. Glutathione and related enzymes in multidrug resistance. Eur J Cancer. 1996;32A:967-978.
12. Harrison DJ, Kharbanda R, Cunningham DS, et al. Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury. J Clin Pathol. 1989;42:624-628.
13. Morrow CS, Cowan KH. Glutathione S-transferases and drug resistance. Cancer Cells. 1990;2:15-22.
14. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol. 1992;27:337-384.
15. Dekant W, Vamvakas S. Mechanisms of xenobiotic-induced renal carcinogenicity. Adv Pharmacol. 1992;23:297-337.
16. Mickisch G, Bier H, Bergler W, et al. P-170 glycoprotein glutathione and associated enzymes in relation to chemoresistance of primary human renal cell carcinomas. Urol Int. 1990;45:170-176.
17. Di Ilio C, Aceto A, Bucciarelli T, et al. Glutathione transferase isoenzymes in normal and neoplastic human kidney tissue. Carcinogenesis. 1991;12:1471-1475.
18. Klone A, Weidner U, Hussatter R, et al. Decreased expression of glutathione S-transferase alpha and pi genes in human renal cell carcinoma. Carcinogenesis. 1990;12:2179-2183.
19. Grignon DJ, Abdel-Malak M, Mertens WC, et al. Glutathione S-transferase expression in renal cell carcinoma: new marker of differentiation. Mod Pathol. 1994;2:186-189.
20. Clairmont A, Ebert T, Weber H, et al. Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinoma. Cancer Res. 1994;54:1319-1323.
21. Patton KT, Tretiakova MS, Yao JL, et al. Expression of ron proto-oncogene in renal oncocytoma and chromophobe renal cell carcinoma. Am J Surg Pathol. 2004;28:1045-1050.
22. Howie AF, Miller WR, Hawkins RA, et al. Expression of glutathione S-transferase B1, B2, mu and pi in breast cancers and their relationship of oestrogen receptor status. Br J Cancer. 1989;60:834-837.
23. Zhou T, Evans AA, London WT, et al. Glutathione S-transferase expression in hepatitis B virus-associated human hepatocellular carcinogenesis. Cancer Res. 1997;57:2749-2753.
24. McQuaid S, O'Brien A, Butler MR, et al. Transcriptional activation of the glutathione S-transferase pi gene in human ureteric and bladder carcinomas. Cancer Lett. 1998;39:209-216.
25. Tiltman AJ, Ali H. Distribution of alpha glutathione S-transferase in ovarian neoplasms: an immunohistochemical study. Histopathology. 2001;39:266-272.